Sponsor Pipeline

Jiangxi Qingfeng Pharmaceutical Co. Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06573008 Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of… Influenza, Human Recruiting
NCT06574503 Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure… Influenza Recruiting
Not specified
NCT06754865 Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment… Acute Exacerbation of Chronic Obstructive Pulmonary Disease Not Yet Recruiting
Disease Areas
COPD (1)
Get alerts when Jiangxi Qingfeng Pharmaceutical Co. Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free